As pioneers in cancer innovation, our mission is to drive discovery and progress to bring significant clinical advances in the fight against cancer. For years, we have led the way in understanding and advancing the fields of cancer biology, immunology, and drug development.
Through our strong commitment and partnerships with clinical researchers, oncologists, pathologists, patients, and more, we aspire to drive a more personalized approach to healthcare using advanced data and technology to identify the right treatment approach for the right patient. With a diverse pipeline of investigational molecules in more than 100 ongoing clinical trials and our ongoing pursuit of scientific discoveries, we will continue to break through the barriers and complexities in oncology to improve the lives of people with cancer.
The compounds and their uses mentioned on this website are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. Do you wish to proceed?
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.